T. Rowe Price Associates’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Sell
442,277
-651,682
-60% -$1.81M ﹤0.01% 2068
2025
Q4
$2.4M Sell
1,093,959
-200,990
-16% -$498K ﹤0.01% 1672
2025
Q3
$3.03M Sell
1,294,949
-892,090
-41% -$1.53M ﹤0.01% 1567
2025
Q2
$3.33M Buy
2,187,039
+1,697,718
+347% +$2.65M ﹤0.01% 1431
2025
Q1
$678K Sell
489,321
-34,766
-7% -$74.1K ﹤0.01% 2137
2024
Q4
$1.19M Sell
524,087
-28,705
-5% -$101K ﹤0.01% 1894
2024
Q3
$2.61M Sell
552,792
-29,483
-5% -$171K ﹤0.01% 1522
2024
Q2
$4.36M Sell
582,275
-30,123
-5% -$369K ﹤0.01% 1262
2024
Q1
$10.4M Buy
612,398
+84,633
+16% +$1.82M ﹤0.01% 1101
2023
Q4
$12M Buy
527,765
+512,450
+3,346% +$8.62M ﹤0.01% 1058
2023
Q3
$234K Buy
15,315
+2,724
+22% +$37.2K ﹤0.01% 2444
2023
Q2
$163K Buy
+12,591
New +$137K ﹤0.01% 2589

Other funds holding CABA